Data from six Liraglutide Effect and Action in Diabetes program trials showed liraglutide and other GLP-1 analogues were safe and effective in improving liver enzymes in overweight type 2 diabetes patients. Liraglutide also fared better than placebo in reducing alanine transaminase levels in patients, researchers wrote in the journal Alimentary Pharmacology and Therapeutics.
Liraglutide shows efficacy in boosting liver enzymes in diabetes
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||